Wintermute Biomedical strengthens its board credentials with the announcement of Prof. Skerritt, former head of Australia's Therapeutic Goods Administration.
The Wintermute Biomedical board is delighted to welcome Professor John Skerritt to Wintermute Biomedical’s Board as a Non-Executive Director. Prof Skerritt is the former Deputy Secretary of Australia’s Department of Health and head of the Therapeutic Goods Administration (2012–2023). He is currently an Enterprise Professor in Health Research Impact at the University of Melbourne and serves on several national and international advisory bodies. His deep expertise in regulation, translation, and health policy will be invaluable as we advance Wintermute’s pipeline and upcoming clinical milestones.